|
Volumn 43, Issue 4, 2011, Pages 1247-1249
|
Diagnosis and classification of hemolytic uremic syndrome: The Hungarian experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BACTERIUM LIPOPOLYSACCHARIDE;
COMPLEMENT FACTOR H;
VON WILLEBRAND FACTOR CLEAVING PROTEINASE;
ADULT;
BLOOD SAMPLING;
CLINICAL ARTICLE;
CLINICAL ASSESSMENT;
CLINICAL FEATURE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DIAGNOSTIC VALUE;
DISEASE CLASSIFICATION;
ENZYME ACTIVITY;
ENZYME LINKED IMMUNOSORBENT ASSAY;
ESCHERICHIA COLI O157;
FEMALE;
GENETIC ANALYSIS;
GRAFT SURVIVAL;
HEMOLYTIC UREMIC SYNDROME;
HUMAN;
HUNGARY;
KIDNEY TRANSPLANTATION;
LABORATORY DIAGNOSIS;
MALE;
PRIORITY JOURNAL;
PROGNOSIS;
RARE DISEASE;
REGISTER;
ADAM PROTEINS;
ADOLESCENT;
ADULT;
ANTIBODIES, BACTERIAL;
AUTOANTIBODIES;
BIOLOGICAL MARKERS;
BLOOD PROTEINS;
CHILD;
CHILD, PRESCHOOL;
COMPLEMENT C3;
COMPLEMENT C3B INACTIVATOR PROTEINS;
COMPLEMENT FACTOR B;
COMPLEMENT FACTOR H;
COMPLEMENT FACTOR I;
ESCHERICHIA COLI O157;
FEMALE;
GENETIC PREDISPOSITION TO DISEASE;
HEMOLYTIC-UREMIC SYNDROME;
HUMANS;
HUNGARY;
INFANT;
LIPOPOLYSACCHARIDES;
MALE;
MIDDLE AGED;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
YOUNG ADULT;
|
EID: 79957615728
PISSN: 00411345
EISSN: 18732623
Source Type: Journal
DOI: 10.1016/j.transproceed.2011.03.071 Document Type: Conference Paper |
Times cited : (6)
|
References (8)
|